Inter-country transfer of Gram-negative organisms carrying the VIM-4 and OXA-58 carbapenem-hydrolysing enzymes [2]

Journal of Antimicrobial Chemotherapy

Volumn 57, Issue 4, 2006, Pages 794-795

  Peleg, Anton Y ^a   Bell, Jan M ^b   Hofmeyr, Ann ^a   Wiese, Peter ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

Acinetobacter baumannii; Carbapenemases; Metallo lactamases; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; AZTREONAM; CARBAPENEM; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; HYDROLASE; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; PROTEIN OXA 58; PROTEIN VIM 4; TEICOPLANIN; TIMENTIN; TOBRAMYCIN; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL GENE; BACTERIAL TRANSMISSION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CASE REPORT; FEMALE; FEVER; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; GREECE; HUMAN; INFECTION CONTROL; INJURY; INTENSIVE CARE UNIT; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHYLOGENY; PSEUDOMONAS AERUGINOSA;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CATHETERIZATION, CENTRAL VENOUS; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; URINARY CATHETERIZATION;

EID: 33645117527     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl036     Document Type: Letter

References (8)

1. Walsh TR, Toleman MA, Poirel L et al. Metallo-β-lactamases: The quiet before the storm? Clin Microbiol Rev 2005; 18: 306-5.
2. VIM-1 in a clinical strain of Pseudomonas aeruginosa. Antimicrob Agents Chemother 2002; 46: 4026-8.
3. Heritier C, Poirel L, Lambert T et al. Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii. Antimicrob Agents Chemother 2005; 49: 3198-202.
4. Peleg AY, Franklin C, Walters LJ et al. OXA-58 and IMP-4 carbapenem-hydrolyzing β-lactamases in an Acinetobacter junii blood culture isolate from Australia. Antimicrob Agents Chemother 2006; 50: 399-400.
5. Pournaras S, Markogiannakis A, Ikonomidis A et al. Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemaseinan intensive care unit. J Antimicrob Chemother 2006; 57: 557-61.
6. Giske CG, Rylander M, Kronvall G. VIM-4 in a carbapenem-resistant strain ofPseudomonas aeruginosa isolated in Sweden. Antimicrob Agents Chemother 2003; 47: 3034-5.
7. Pitout JD, Gregson DB, Poirel L et al. Detection of Pseudomonas aeruginosa producing metallo-β-lactamases in a large centralized laboratory. J Clin Microbiol 2005; 43, 3129-35.
8. IMP-4 among gram-negative pathogens in a clinical setting in Australia. Clin Infect Dis 2005; 41: 1549-56.